rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5B
|
pubmed:dateCreated |
2007-11-1
|
pubmed:abstractText |
The aim of this study was to elucidate the prognostic value of the immunohistochemical detection of the androgen receptor (AR) status, the chromogranin A assessment of neuroendocrine differentiation (NED) and the CD34 assessment of microvessel density (MVD) with time-to-biochemical failure among surgically treated patients with clinically localized prostate cancer. Patients and
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3651-60
|
pubmed:meshHeading |
pubmed-meshheading:17972531-Aged,
pubmed-meshheading:17972531-Antigens, CD34,
pubmed-meshheading:17972531-Cell Differentiation,
pubmed-meshheading:17972531-Chromogranin A,
pubmed-meshheading:17972531-Disease-Free Survival,
pubmed-meshheading:17972531-Humans,
pubmed-meshheading:17972531-Immunohistochemistry,
pubmed-meshheading:17972531-Male,
pubmed-meshheading:17972531-Middle Aged,
pubmed-meshheading:17972531-Multivariate Analysis,
pubmed-meshheading:17972531-Neovascularization, Pathologic,
pubmed-meshheading:17972531-Neurosecretory Systems,
pubmed-meshheading:17972531-Prostatectomy,
pubmed-meshheading:17972531-Prostatic Neoplasms,
pubmed-meshheading:17972531-Receptors, Androgen,
pubmed-meshheading:17972531-Time Factors,
pubmed-meshheading:17972531-Treatment Failure
|
pubmed:articleTitle |
Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
|
pubmed:affiliation |
Department of Pathology, Evangelismos Hospital, Athens, Greece.
|
pubmed:publicationType |
Journal Article
|